Related Experiment Video
Updated: Oct 29, 2025

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
Published on: September 25, 2018
Enteric plexus neuropathy associated with PD-L1 blockade in a patient with small-cell lung cancer
Ioannis P Trontzas1, Vasiliki E Rapti1, Nikolaos K Syrigos1
13rd Department of Internal Medicine, Oncology Unit, Sotiria General Hospital, Athens School of Medicine, 11527, Greece.
Abstract:
Immune checkpoint inhibitors have revolutionized the management of patients with cancer. The increasing use of these agents has brought up a new set of adverse events which are widely heterogenous and potentially life-threatening. Rare immune-related adverse events associated with nervous system have not been described thoroughly, but their early recognition and management may be crucial. Immune-related autonomic neuropathy may be presented with a constellation of symptoms ranging from gastrointestinal and urinary complaints, to sweating and hypotension. Intestinal pseudo-obstruction as consequence of immune-related myenteric autonomic neuropathy is an under-recognized, not-well described and potentially fatal adverse event. We herein, present a unique case of enteric plexus neuropathy induced by PD-L1 blockade in a patient with small-cell lung cancer.
Insights
Immune checkpoint inhibitors can cause rare, severe nervous system side effects. This case highlights a potentially fatal intestinal issue from PD-L1 blockade in lung cancer patients.
Area of Science:
- Oncology
- Neuroimmunology
- Gastroenterology
Background:
- Immune checkpoint inhibitors (ICIs) have transformed cancer treatment.
- Increasing ICI use reveals diverse, potentially severe immune-related adverse events (irAEs).
- Nervous system irAEs are uncommon but critical to recognize.
Observation:
- Immune-related autonomic neuropathy presents with varied symptoms, including gastrointestinal and cardiovascular issues.
- Intestinal pseudo-obstruction due to immune-related myenteric autonomic neuropathy is under-recognized.
- A unique case of enteric plexus neuropathy induced by PD-L1 blockade is presented.
Findings:
- PD-L1 blockade can induce enteric plexus neuropathy, leading to intestinal pseudo-obstruction.
- This rare irAE is potentially fatal if not promptly identified and managed.
- Early diagnosis and intervention are crucial for patient outcomes.
Implications:
- Clinicians should consider enteric plexus neuropathy in patients on PD-L1 inhibitors presenting with gastrointestinal dysmotility.
- Further research is needed to understand the mechanisms and optimal management of ICI-induced autonomic neuropathies.
- This case underscores the importance of vigilance for rare irAEs in the evolving landscape of cancer immunotherapy.
More Related Videos
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
10:18Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
Published on: July 7, 2023
Related Concept Videos
Nerve Supply of the GI Tract
The enteric nervous system consists of two major plexuses: the myenteric plexus (Auerbach's plexus) and the submucosal plexus (Meissner's plexus). These plexuses are located within the layers of...
Spinal Nerves: Plexus I
The Cervical Plexus
The cervical plexus, formed by the anterior rami of the first four...
Spinal Nerves: Plexus II
The Lumbar Plexus
The lumbar plexus is situated within the lumbar region of the back and is primarily formed by the first four lumbar spinal nerves (L1 to L4). This plexus extends its branches into several nerves, including the...
Neural Regulation
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists